Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Rafarma Launched Two New Oncology Products
At the beginning of 2019, Rafarma JSC launched the first anticancer drugs Rozustin® (INN Bendamustin) and Pemelan® (INN Pemetrexed) in its own portfolio. Rosustin® for leukemia treatment has become th...
7.85 billion rubles will be invested to develop Rafarma
Protek has bought up 40 thousand shares totaling 7.825 billion rubles, that were newly issued by Rafarma, a Lipetsk-based pharmaceutical manufacturer
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
Swissmedic Started to Enter GMP Compliance Information into ...
ACG Expands in Brazil
Fedegari, Innovative Way to Thermally Sterilize Hyaluronic A...
Subscribe to Newsletter!
© GMP news